Scientists develop blindness test for diabetics
Australian scientists have developed a groundbreaking trial to detect potential blindness in people with diabetes.
The Remote-I technology, developed by the Commonwealth Scientific Industrial Research Organization, will allow diabetics to have their eyes tested by their regular family doctor, removing unnecessary and often expensive visits to specialists.
Yogi Kanagasingam, leader of the first trial of the technology in Perth, said that one in three diabetics suffered from diabetic retinopathy, a condition which often leads to blindness.
The new technology, Yogi Kanagasingam, developed by CSIRO, is able to be used by general practitioners and can identify the condition.
“Vision loss or blindness caused by the condition can often be prevented through early detection and timely treatment,” Kanagasingam said onMonday.
“GPs are (on) the frontline in managing chronic diseases, such as diabetes.
“This is the first step in developing a DR screening system that will helps GPs prioritize patients for treatment and surgery to prevent disease complications.
“If we can pick up early changes and provide the appropriate intervention, we can prevent blindness.”
During the trial, to be held at Perth’s GP Superclinic, the Remote-I system will capture high-resolution images of 200 patients’ retinas and upload them to a cloud-based system.
The images will then examined by a specialist.
“This project will provide a breakthrough in the early detection and diagnosis of diabetic retinopathy in primary care, further breaking down the barriers in specialist access to services in the community,” Amitha Preetham, director of the GP Superclinic, said.
“This tool provides a valuable adjunct in the delivery of our comprehensive onestop diabetes services that already exist on site, which includes GPs who are upskilled in diabetes, working alongside other specialists and allied health services to provide patientcentered healthcare.” be
If we can pick up early changes and provide the appropriate intervention, we can prevent blindness.” the trial leader of